Annual CAPEX
N/A
31 December 2023
Summary:
GlucoTrack annual capital expenditures is not available.GCTK CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CAPEX
N/A
30 September 2024
Summary:
GlucoTrack quarterly capital expenditures is not available.GCTK Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CAPEX
N/A
30 September 2024
Summary:
GlucoTrack TTM capital expenditures is not available.GCTK TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GCTK CAPEX Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
GCTK CAPEX High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | ||||||
| 5 y | 5 years | ||||||
| alltime | all time |
GlucoTrack CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2019 | $23.00 K(+325.9%) | $400.00(-96.8%) | $22.90 K(-6.1%) |
| Sept 2019 | - | $12.60 K(+260.0%) | $24.40 K(+82.1%) |
| June 2019 | - | $3500.00(-45.3%) | $13.40 K(+22.9%) |
| Mar 2019 | - | $6400.00(+236.8%) | $10.90 K(+101.9%) |
| Dec 2018 | $5400.00(-72.3%) | $1900.00(+18.8%) | $5400.00(+54.3%) |
| Sept 2018 | - | $1600.00(+60.0%) | $3500.00(-78.8%) |
| June 2018 | - | $1000.00(+11.1%) | $16.50 K(-12.7%) |
| Mar 2018 | - | $900.00(>+9900.0%) | $18.90 K(-3.1%) |
| Dec 2017 | $19.50 K | $0.00(-100.0%) | $19.50 K(-5.8%) |
| Sept 2017 | - | $14.60 K(+329.4%) | $20.70 K(-40.9%) |
| June 2017 | - | $3400.00(+126.7%) | $35.00 K(-35.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2017 | - | $1500.00(+25.0%) | $54.00 K(-29.4%) |
| Dec 2016 | $76.50 K(-46.8%) | $1200.00(-95.8%) | $76.50 K(-38.5%) |
| Sept 2016 | - | $28.90 K(+29.0%) | $124.30 K(-27.4%) |
| June 2016 | - | $22.40 K(-6.7%) | $171.20 K(+10.0%) |
| Mar 2016 | - | $24.00 K(-51.0%) | $155.60 K(+8.3%) |
| Dec 2015 | $143.70 K(+126.3%) | $49.00 K(-35.4%) | $143.70 K(+34.7%) |
| Sept 2015 | - | $75.80 K(+1014.7%) | $106.70 K(+209.3%) |
| June 2015 | - | $6800.00(-43.8%) | $34.50 K(+24.5%) |
| Mar 2015 | - | $12.10 K(+0.8%) | $27.70 K(+77.6%) |
| Dec 2014 | $63.50 K | $12.00 K(+233.3%) | $15.60 K(+333.3%) |
| Sept 2014 | - | $3600.00 | $3600.00 |
FAQ
- What is the all time high annual CAPEX for GlucoTrack?
- What is the all time high quarterly CAPEX for GlucoTrack?
- What is the all time high TTM CAPEX for GlucoTrack?
What is the all time high annual CAPEX for GlucoTrack?
GlucoTrack all-time high annual capital expenditures is $143.70 K
What is the all time high quarterly CAPEX for GlucoTrack?
GlucoTrack all-time high quarterly capital expenditures is $75.80 K
What is the all time high TTM CAPEX for GlucoTrack?
GlucoTrack all-time high TTM capital expenditures is $171.20 K